Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 26/8/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 1M
-170.8x14.16x-193.81x-.--% 40.64B
19.75x1.9x10.94x1.02% 23.32B
17.26x1.34x7.63x5.04% 7.39B
353.44x - - - 5.42B
47.81x8.51x30.25x1.09% 2.95B
-22.98x - - - 2.05B
-34.01x - - -.--% 1.97B
30.46x1.08x9.04x0.83% 1.75B
12.31x1.29x5.06x6.15% 1.65B
Average 28.14x 4.71x -21.81x 2.02% 8.71B
Weighted average by Cap. -49.79x 8.48x -95.91x 0.95%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited